Skip to content

Cognitive Training in Heart Failure Study (CogTrain-HF)

Cognitive Training in Heart Failure Study (CogTrain-HF)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02415517
Acronym
CogTrain-HF
Enrollment
107
Registered
2015-04-14
Start date
2014-01-31
Completion date
2019-12-04
Last updated
2020-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment, Congestive Heart Failure

Keywords

Cognitive training, Cognitive impairment, Heart failure, Cognition

Brief summary

The daily routine in clinical settings often showed cognitive impairments in patients with congestive heart failure, particularly in terms of executive functions, episodic memory, perceptual speed and attention. It is assumed that cognitive impairments in patients with congestive heart failure may lead to deficits in medication-adherence and self-care abilities, resulting in increased healthcare costs. Recent studies reported performance improvements after cognitive training that transferred to new, untrained tasks and abilities in healthy subjects across a wide range of ages. This study investigates the effects of cognitive training in patients with congestive heart failure.

Detailed description

Cognitive functions of patients with congestive heart failure (NYHA II-III) before (pretest) and after (posttest) cognitive-training intervention are investigated. Changes in cognitive functions are compared to changes in two control groups: 1) age and gender matched active control group 2) age and gender matched passive waiting list control group. The neuropsychological test battery applied at pretest and posttest includes measures of episodic memory, working memory, short-term memory, executive functions, perceptual speed and intelligence. In addition, the investigators apply standardized questionnaires of self-assessed quality of life, cognitive functioning in daily life, selfcare, and psychological well-being (depression, anxiety and personality). Relevant physiological data such as ejection fraction, heartrate, N-terminal pro brain natriuretic peptide (NT-pro-BNP) as well as drug blood level are recorded.

Interventions

BEHAVIORALCognitive training

Cognitive training on computer. Six sessions with different tasks: Tiere merken & Räumlich visuelles Training (application BrainTwister) and Taskswitching (programmed with eprime)

BEHAVIORALTest of general knowledge

Training of general knowledge on computer. Six sessions with different topics.

Sponsors

Deutsche Stiftung für Herzforschung
CollaboratorOTHER
Universität des Saarlandes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Participants were enrolled in Treatment-Group, Waitinglist-Group, or Shamtraining-Group

Intervention model description

Pre-Test, Intervention, Post-Test, Follow-Up

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Congestive heart failure * NYHA II-III

Exclusion criteria

* Psychosis * Dementia * Major depression * Reanimation (\<3month) * Patients with assist device system

Design outcomes

Primary

MeasureTime frameDescription
Training effects3 weeksImprovement in performance in the last trainingssession compared with the performance in the first trainingssession. Performance will be assessed by computesoftware.

Secondary

MeasureTime frameDescription
Transfer effects5 weeksTransfer effects are measured by comparing cognitive functions in patients with congestive heart failure before and after cognitive training. Cognitive functions will be assessed by different paper-and-pencil tests and computerbased tests.
Changes in quality of life and psychological well-being5 weeksChanges in quality of life and psychological well-being as the result of cognitive training measured by psychological questionnaires and tests.
Long-term benefits of cognitive training in patients with congestive heart failure.6 monthFollow-up assessment by 6 months after training. Long-term benefits will be measured by different paper-and-pencil tests and computerbased tests as well as psychological questionnaires and tests.
Compliance with medication5 weeksCompliance with medication measured as serum level of medication and heart failure-specific self-care duties.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026